Hiring in an Evolving Market

Tyler Kern interviewed Hannah Anderson and Chris Lester to discuss hiring in an evolving market and what to know for the current climate. Hannah Anderson is the Managing Director at Catapult Solutions and is joined by Chris Lester, Chief Revenue Officer at Catapult Solutions Group.

There have been many readjustments over the years, and it is a candidate-driven market. Anderson highlighted remote work being a crucial part of the decision-making market in the more recent years. When COVID struck, the market went beyond the in-town network experience to a more expansive market. Furthermore, the expansion with the current market called for the competition to increase among job fields. Companies are having to make game plans to accommodate current market shifts.

Candidates are commonly looking for flexibility among hiring companies. Rate is another competing factor when candidates are looking to apply for companies. Benefits, technology, and a rich culture are also innovative ways to attract candidates.

Over the next few years, continuing education will be crucial for companies to implement consistency and retention among their teams. These will create room for growth among the hierarchy and structure within a company. Lester shared how companies who continue to expand and advance will have the opportunity to hire candidates and grow a diverse team. “It’s about putting the correct person…culturally and [with the right] skillset and mindset, and drive into that role to help [companies] fill that need,” said Anderson.

Follow us on social media for the latest updates in B2B!

Image

Latest

organoids
Growing the Future of Cancer Research: Inside the Promise of Organoids
April 19, 2025

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Read More
Immuno-Oncology
Shaping the Future of Cancer Care Through Immuno-Oncology
April 19, 2025

In the ever-evolving world of cancer treatment, immuno-oncology (IO) continues to stand at the forefront of innovation. With recent FDA approvals for TIL therapies and bispecific antibodies, and new developments in CAR-T technologies, the field is rapidly expanding into combination-based strategies that integrate with standard care. Researchers are also exploring how to overcome challenges posed…

Read More
Evolving Biomarkers: Charting the Future of Precision Medicine
April 19, 2025

In a rapidly shifting landscape of personalized medicine, biomarkers have become central to shaping the way drug development and clinical trials unfold. From predicting therapeutic response to identifying optimal patient populations, the complexity and scope of biomarker use has increased alongside technological advances. A key success story like the BCR-ABL biomarker in chronic myeloid leukemia…

Read More
Drug Discovery
Exploring Artificial Intelligence in Drug Discovery
April 19, 2025

Artificial intelligence is rapidly reshaping the drug discovery process, moving from augmenting research to actively driving innovation. As biotech companies face soaring R&D costs and long development cycles, AI promises a breakthrough: slashing drug development time by nearly half while improving accuracy in identifying promising compounds. With global pharmaceutical R&D spending projected to exceed $230…

Read More